Riskpilot← Back to searchSign inGet full accessJANSSEN-CILAG AS
ASActiveOrg 975332802Drammensveien 288, 0283 OsloWholesale of pharmaceutical and medical goods · NACE 4646Est. 199555 employees
Revenue 2024
NOK 1,4B
-1% vs 2023
EBITDA margin
4.4%
-21% vs 2023
Equity ratio
12.6%
Financial strength
Net profit 2024
NOK 52,2M
-19% vs 2023
| Revenue | NOK 1,4B | -1% |
| EBITDA | NOK 61,4M | -21% |
| Net profit | NOK 52,2M | -19% |
| Total assets | NOK 520,7M | -4% |
| Equity | NOK 65,4M | +4% |
| Employees | 55 | — |
Legal name
JANSSEN-CILAG AS
Org number
975332802
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
22. mai 1995
Share capital
NOK 85 093
Employees
55 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Address
Drammensveien 288, 0283 Oslo
Phone
+4724126500
Email
jacno@its.jnj.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 452 325 | 449 217 | 441 080 | 542 549 | 686 581 | 991 687 | 1 217 100 | 1 150 827 | 1 126 689 | 1 251 222 | 1 359 128 | 1 307 307 | 1 510 490 | 1 398 786 | 1 394 645 | 1 384 983 |
| Staff expenses | −63 947 | −65 454 | −47 035 | −53 865 | −58 015 | −113 742 | −133 005 | −116 964 | −101 778 | −99 887 | −98 470 | −98 141 | −91 515 | −77 616 | −89 625 | −89 971 |
| EBITDA | 19 797 | 19 934 | 22 478 | 31 095 | 52 941 | 54 825 | 78 123 | 112 401 | 73 503 | 95 445 | 83 528 | 58 928 | 86 819 | 67 390 | 77 824 | 61 371 |
| Depreciation & amort. | −1 124 | −1 019 | −913 | −773 | −1 087 | −22 102 | −29 259 | −28 307 | −25 980 | −25 949 | −13 556 | −1 038 | −1 123 | −1 221 | −1 163 | −2 519 |
| EBIT | 18 674 | 18 915 | 21 565 | 30 322 | 51 854 | 32 723 | 48 864 | 84 094 | 47 523 | 69 496 | 69 973 | 57 891 | 85 696 | 66 170 | 76 661 | 58 852 |
| Net financials | 3 556 | −2 280 | 2 763 | 1 485 | −8 049 | −7 350 | −1 736 | 860 | −171 | 479 | 1 524 | −175 | 660 | 2 | 1 063 | 10 478 |
| Profit before tax | 22 230 | 16 635 | 24 281 | 31 808 | 43 805 | 25 373 | 47 128 | 84 954 | 47 352 | 69 976 | 71 496 | 57 715 | 86 357 | 66 171 | 77 724 | 69 330 |
| Tax | 6 770 | 4 972 | 7 072 | 9 246 | 12 487 | 7 325 | 14 048 | 18 648 | 12 061 | 17 233 | 14 584 | 15 525 | 20 238 | 15 513 | 13 146 | 17 115 |
| Net profit | 15 460 | 11 663 | 17 209 | 22 561 | 31 318 | 18 048 | 33 080 | 66 307 | 35 292 | 52 742 | 56 912 | 42 191 | 66 119 | 50 658 | 64 578 | 52 215 |
| Item | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 223 940 | 162 136 | 156 650 | 255 455 | 250 453 | 435 361 | 483 949 | 396 613 | 487 894 | 931 456 | 393 433 | 623 421 | 441 325 | 441 950 | 541 004 | 520 750 |
| Equity | 51 448 | 63 111 | 80 320 | 102 882 | 134 200 | 103 904 | 136 984 | 203 291 | 238 583 | 53 025 | 109 937 | 13 127 | 79 246 | 96 746 | 63 184 | 65 399 |
| Long-term debt | 2 121 | 0 | 0 | 772 | 1 281 | 939 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 550 | 0 |
| Short-term debt | 170 371 | 99 025 | 76 330 | 151 801 | 114 973 | 330 518 | 346 965 | 193 322 | 249 312 | 878 431 | 283 496 | 610 260 | 350 475 | 343 984 | 475 220 | 455 350 |
| Total debt | 172 491 | 99 025 | 76 330 | 152 574 | 116 253 | 331 456 | 346 965 | 193 322 | 249 312 | 878 431 | 283 496 | 610 260 | 350 475 | 343 984 | 475 771 | 455 350 |
EBITDA margin
4.4%
This company
15.8%
Market median
-72% vs market
20092024
Equity ratio
12.6%
This company
38.2%
Market median
-67% vs market
20092024
Return on equity
79.8%
This company
18.4%
Market median
+334% vs market
20092024
Net profit margin
3.8%
This company
8.1%
Market median
-53% vs market
20092024
Asset turnover
2.66×
This company
1.12×
Market median
+138% vs market
20092024
Debt / equity
6.96×
This company
0.62×
Market median
-1023% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MK Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
BS Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
DJ Chief Executive Officer | Chief Executive Officer | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2021 | — | — | |
| Chairman | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 2023 | — | — | |
| Chairman | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Janssencilag Ab | Company | 100.0% | 100.0% | 2024 |
Janssen-Cilag Ab | Company | 100.0% | 100.0% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of JANSSEN-CILAG AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mario Klesse | Chief Executive Officer | 0 companies |
| Barbara Suter | Chief Executive Officer | 0 companies |
| Duarte Joao Lourinho Marchand | Chief Executive Officer | 0 companies |
| Heidi Gusfre Skårdal | Board of Directors | 0 companies |
| Anne Merete Sveaass | Chairman | 0 companies |
| Raphael Patricot | Board of Directors | 0 companies |
| Anne Håvi | Board of Directors | 0 companies |
| Nataliya Sycheva | Board of Directors | 0 companies |
| Charlotte Krogh | Board of Directors | 0 companies |
| Berkeley Alexander Vincent | Chairman | 0 companies |